Adalimumab enhances health-related quality of life in patients with active ankylosing spondylitis - Results from the atlas trial

Παρόμοια τεκμήρια

• Adalimumab improves health-related quality of life in patients with active ankylosing spondylitis - The ATLAS trial.
  ανά: Van der Heijde, D, κ.ά.
  Έκδοση: (2005)
• Adalimumab improves physical functioning and work productivity in ankylosing spondylitis (AS) patients: Results from ATLAS.
  ανά: van der Heijde, D, κ.ά.
  Έκδοση: (2006)
• Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing spondylitis: results from the adalimumab trial evaluating long-term safety and efficacy for ankylosing spondylitis (ATLAS).
  ανά: Revicki, D, κ.ά.
  Έκδοση: (2008)
• Improved physical functioning and work productivity in ankylosing spondylitis (AS) patients who were treated with adalimumab-ATLAS trial results
  ανά: Vanderheijde, D, κ.ά.
  Έκδοση: (2007)
• Treatment with adalimumab reduces signs and symptoms and induces partial remission in patients with ankylosing spondylitis (AS): 1-year results from ATLAS.
  ανά: van der Heijde, D, κ.ά.
  Έκδοση: (2006)